Recent advances in neoadjuvant therapy for breast cancer

Neoadjuvant trials for early breast cancer have accelerated the identification of novel active agents, enabling streamlined conduct of registration trials with fewer subjects. Measurement of neoadjuvant drug effects has also enabled the identification of patients with high risk of distant recurrence...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Fac Rev
Egile Nagusiak: Potter, David A, Herrera-Ponzanelli, César A, Hinojosa, Diego, Castillo, Rafael, Hernandez-Cruz, Irwin, Arrieta, Victor A, Franklin, Michael J, Yee, Douglas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Faculty Opinions Ltd 2021
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894264/
https://ncbi.nlm.nih.gov/pubmed/33659921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/r/10-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak